Document is current
Any future updates will be listed below
-
Authors
Jensen, Maj-Britt http://orcid.org/0000-0001-5348-3040
Lænkholm, Anne-Vibeke
Nielsen, Torsten O.
Eriksen, Jens Ole
Wehn, Pernille
Hood, Tressa
Ram, Namratha
Buckingham, Wesley
Ferree, Sean
Ejlertsen, Bent
- License Information
-
More Information
Article History
Received: 19 March 2018
Accepted: 2 July 2018
First Online: 27 July 2018
Ethics approval and consent to participate
: The Biomedical Research Ethics Committee of the Danish Capital Region approved the protocol (H-15012740), and granted dispensation from consent.
: Not applicable.
: MBJ: None. AVL: Nanostring Technologies, Inc.: grant, Roche: grant. TON: Nanostring Technologies, Inc.: personal fees, non-financial support, other: licensing agreement, patent. JOE: none. PW: none. TH: Nanostring Technologies, Inc.: personal fees, other: employee and stock. NR: Nanostring Technologies, Inc.: personal fees: employee. WB: Nanostring Technologies, Inc.: personal fees: employee. SF: Nanostring Technologies, Inc.: other: employee and stock, patent. BE: Nanostring Technologies, Inc:.grant: institutional. Novartis: grant: institutional. Roche: Grant: institutional.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
